SEC Form 4 · accession 0001179110-18-002352
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Director
Period of report
Feb 13, 2018
Accepted (ET)
Feb 20, 2018 · 10:59 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 13, 2018 | M | 25,000 | $4.29 | A | 221,700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.29 | Feb 16, 2018 | M | 25,000 | D | Jan 1, 2010 | Jan 1, 2029 | Common Stock | 25,000 | 163,518 | D |
Explanation of responses
- F1Exercisable as to 50,000 shares commencing on January 1, 2010, 44,639 shares commencing on January 1, 2011, 26,690 shares commencing on January 1, 2012, and 26,690 shares commencing on January 1, 2013.